Inventor · disambiguated record
Eszter Nagy
Also filed as: NAGY ESZTER
41 granted patents·35 pending applications·199 citations·filing 2001–2025
97Inventor score
Files withINTERCELL AG27ARSANIS BIOSCIENCES GMBH13MEINKE ANDREAS11JANSSEN PHARMACEUTICALS INC4X4 PHARMACEUTICALS AUSTRIA GMBH4
Top patents by PatentIndex Score
76 records- 0192US10940191B2MDR E. coli specific antibodyX4 PHARMACEUTICALS AUSTRIA GMBH·Filed 2018·Granted Mar 9, 2021·9 cites·27 claims
- 0292US8372411B2S. pneumoniae antigensINTERCELL AG·Filed 2009·Granted Feb 12, 2013·19 cites·30 claims
- 0392US7438912B2S.agalactiae antigens I + IIINTERCELL AG·Filed 2004·Granted Oct 21, 2008·46 cites·7 claims
- 0491US7635487B2S. pneumoniae antigensINTERCELL AG·Filed 2004·Granted Dec 22, 2009·29 cites·16 claims
- 0590US10206992B2MDR E. coli specific antibodyARSANIS BIOSCIENCES GMBH·Filed 2016·Granted Feb 19, 2019·9 cites·23 claims
- 0689US9849169B2MDR E. coli specific antibodyARSANIS BIOSCIENCES GMBH·Filed 2014·Granted Dec 26, 2017·13 cites·5 claims
- 0789US7771728B2Method for identification, isolation and production of antigens to a specific pathogenINTERCELL AG·Filed 2006·Granted Aug 10, 2010·10 cites·13 claims
- 0887US11433080B2Antiviral treatmentCEBINA GmbH·Filed 2021·Granted Sep 6, 2022·2 cites·23 claims
- 0986US8323660B2Method for identification, isolation and production of antigens to a specific pathogenMEINKE ANDREAS·Filed 2010·Granted Dec 4, 2012·7 cites·6 claims
- 1083US7927607B2S. agalactiae antigens I and IIINTERCELL AG·Filed 2008·Granted Apr 19, 2011·5 cites·10 claims
- 1182US12274742B2MDR E. coli immunogenJANSSEN PHARMACEUTICALS INC·Filed 2022·Granted Apr 15, 2025·0 cites·11 claims
- 1282US8449892B2S. agalactiae antigens I and IIMEINKE ANDREAS·Filed 2011·Granted May 28, 2013·5 cites·32 claims
- 1381US8715688B2Method for identification, isolation and production of antigens to a specific pathogenMEINKE ANDREAS·Filed 2012·Granted May 6, 2014·3 cites·16 claims
- 1479US8129165B2Borrelia antigensLUNDBERG URBAN·Filed 2007·Granted Mar 6, 2012·5 cites·8 claims
- 1578US8303961B2Borrelia antigensLUNDBERG URBAN·Filed 2012·Granted Nov 6, 2012·3 cites·13 claims
- 1677US7638136B2Streptococcus pyogene antigensINTERCELL AG·Filed 2004·Granted Dec 29, 2009·10 cites·16 claims
- 1776US8343510B2Protective proteins of S. agalactiae, combinations thereof and methods of using the sameINTERCELL AG·Filed 2008·Granted Jan 1, 2013·1 cites·15 claims
- 1874US11529405B2MDR E. coli immunogenJANSSEN PHARMACEUTICALS INC·Filed 2021·Granted Dec 20, 2022·0 cites·27 claims
- 1974US8236325B2S. epidermidis antigensMEINKE ANDREAS·Filed 2009·Granted Aug 7, 2012·1 cites·16 claims
- 2074US7968297B2Method for identification, isolation and production of antigens to a specific pathogenINTERCELL AG·Filed 2002·Granted Jun 28, 2011·7 cites·16 claims
- 2174US2025170230A1Mdr e. coli immunogenJANSSEN PHARMACEUTICALS INC·Filed 2025·Application pending·0 cites
- 2273US8236326B2Klebsiella antigensBAKSHI SHARMILA·Filed 2008·Granted Aug 7, 2012·2 cites·11 claims
- 2372US8617574B2Nontypable Haemophilus influenzae antigensVON GABAIN ALEXANDER·Filed 2010·Granted Dec 31, 2013·4 cites·8 claims
- 2470US8361476B2Vaccine composition comprising an antigen and a peptide having adjuvant propertiesINTERCELL AG·Filed 2001·Granted Jan 29, 2013·4 cites·5 claims
- 2569US9914767B2Cross-reactive Staphylococcus aureus antibodyARSANIS BIOSCIENCES GMBH·Filed 2013·Granted Mar 13, 2018·3 cites·21 claims
- 2668US7628994B2S. epidermidis antigensINTERCELL AG·Filed 2004·Granted Dec 8, 2009·1 cites·9 claims
- 2767US8900564B2Vaccine composition comprising an antigen and a peptide having adjuvant propertiesFritz Jörg·Filed 2008·Granted Dec 2, 2014·1 cites·15 claims
- 2865US8349336B2Streptococcus pyogenes antigensINTERCELL AG·Filed 2009·Granted Jan 8, 2013·0 cites·15 claims
- 2964US11273163B2Antiviral treatmentCEBINA GmbH·Filed 2021·Granted Mar 15, 2022·0 cites·8 claims
- 3064US2023220055A1Antibodies targeting a galactan-based o-antigen of k. pneumoniaeX4 PHARMACEUTICALS AUSTRIA GMBH·Filed 2022·Application pending·0 cites
- 3162US2011236414A1Bacterial Polysaccharide-Polypeptide Conjugate CompositionsINTERCELL AG·Filed 2009·Application pending·0 cites
- 3262US2010221277A1Chlamydia pneumoniae antigensMEINKE ANDREAS·Filed 2009·Application pending·0 cites
- 3362US2013122030A1S. epidermidis antigensINTERCELL AG·Filed 2013·Application pending·0 cites
- 3461US8241643B2Peptides protective against S. pneumoniae and compositions, methods and uses relating theretoMEINKE ANDREAS·Filed 2009·Granted Aug 14, 2012·0 cites·17 claims
- 3560US8952135B2S. agalactiae antigens I and IIVALNEVA AUSTRIA GMBH·Filed 2013·Granted Feb 10, 2015·0 cites·11 claims
- 3660US2014212448A1Klebsiella antigensVALNEVA AUSTRIA GMBH·Filed 2013·Application pending·0 cites
- 3758US8431128B2Enterococcus antigensMEINKE ANDREAS·Filed 2011·Granted Apr 30, 2013·0 cites·8 claims
- 3858US2006240029A1Chlamydia pneumoniae antigensINTERCELL AG·Filed 2004·Application pending·0 cites
- 3958US2013287782A1Enterococcus antigensMEINKE ANDREAS·Filed 2013·Application pending·0 cites
- 4057US8372410B2S. epidermidis antigensINTERCELL AG·Filed 2012·Granted Feb 12, 2013·0 cites·14 claims
- 4157US2008175856A1Enterococcus AntigensINTERCELL AG·Filed 2004·Application pending·0 cites
- 4256US8529910B2Enterococcus antigensMEINKE ANDREAS·Filed 2011·Granted Sep 10, 2013·0 cites·18 claims
- 4355US8529911B2Small Streptococcus pyogenes antigens and their useMEINKE ANDREAS·Filed 2007·Granted Sep 10, 2013·0 cites·18 claims
- 4454US8637052B2Klebsiella antigensBAKSHI SHARMILA·Filed 2012·Granted Jan 28, 2014·0 cites·80 claims
- 4553US2013216583A1Vaccine composition comprising an antigen and a peptide having adjuvant propertiesINTERCELL AG·Filed 2013·Application pending·0 cites
- 4653US2013136761A1S. pneumoniae antigensINTERCELL AG·Filed 2013·Application pending·0 cites
- 4753US2013122047A1Streptococcus pyogenes antigensINTERCELL AG·Filed 2012·Application pending·0 cites
- 4852US8445001B2Peptides protective against S. pneumoniae and compositions, methods and uses relating theretoMEINKE ANDREAS·Filed 2012·Granted May 21, 2013·0 cites·17 claims
- 4951US12103962B2E. coli specific antibodiesJANSSEN PHARMACEUTICALS INC·Filed 2014·Granted Oct 1, 2024·0 cites·4 claims
- 5051US2020339668A1Klebsiella pneumoniae o3 specific antibodiesX4 PHARMACEUTICALS AUSTRIA GMBH·Filed 2020·Application pending·0 cites
Showing the top 50 of 76 patent records by PatentIndex Score.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →